리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2025년 08월
페이지 정보:영문 214 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 개 관절염 치료 시장은 2030년까지 30억 달러에 도달
2024년에 24억 달러로 추정되는 세계의 개 관절염 치료 시장은 2024-2030년의 분석 기간에 CAGR 3.5%로 성장하며, 2030년에는 30억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 의약품 치료는 CAGR 4.1%를 기록하며, 분석 기간 종료시에는 14억 달러에 달할 것으로 예측됩니다. 보충제 치료 분야의 성장률은 분석 기간 중 CAGR 3.4%로 추정됩니다.
미국 시장은 6억 6,100만 달러로 추정, 중국은 CAGR 6.7%로 성장 예측
미국의 개 관절염 치료 시장은 2024년에 6억 6,100만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 분석 기간인 2024-2030년 CAGR을 6.7%로, 2030년까지 6억 40만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 1.4%와 2.7%로 예측됩니다. 유럽에서는 독일이 CAGR 2.0%로 성장할 것으로 예측됩니다.
세계의 개 관절염 치료 시장 - 주요 동향과 촉진요인 정리
반려동물 보호자들 사이에서개 관절염에 대한 관심이 높아지는 이유는 무엇인가?
반려견의 관절염은 특히 수의학적 치료의 발전으로 반려견의 수명이 길어짐에 따라 큰 건강 문제가 되고 있습니다. 이 퇴행성 관절 질환은 전 세계 수백만 마리의 반려동물에게 통증, 이동성 저하, 삶의 질 저하를 유발하는 질환으로, 전 세계에서 수백만 마리의 반려동물에게 영향을 미치고 있습니다. 관절 건강에 대한 보호자들의 인식이 높아지면서 반려동물의 인간화 추세와 맞물려 관절염 치료제 시장이 크게 확대되고 있습니다. 수의사들은 현재 예후를 개선하기 위해 조기 진단과 다양한 치료 접근법에 중점을 두고 있으며, 이는 의약품 및 비의약품 솔루션에 대한 수요를 주도하고 있습니다. 또한 반려견의 비만 유병률 증가는 관절염을 악화시키고 효과적인 치료 옵션의 필요성을 더욱 부추기고 있습니다.
수의학 분야의 기술 혁신은 어떻게 관절염 관리를 개선하고 있는가?
개 관절염 치료 시장은 최근 수년간 큰 진전을 이루었으며, 새로운 치료법이 통증 완화 및 관절 지지력을 향상시키고 있습니다. 줄기세포 치료와 혈소판 풍부 혈장(PRP) 치료를 포함한 재생의료는 손상된 연골을 복구하고 질환의 진행을 늦출 수 있다는 점에서 각광받고 있습니다. 통증 경로를 표적으로 하는 단일 클론 항체와 같은 생물제제의 발전은 관절염 관리에 혁명을 가져왔으며, 부작용이 적고 장기적인 완화를 제공합니다. 또한 오메가 3 지방산과 글루코사민 보충제를 포함한 건강기능식품의 개발로 비침습적 치료의 선택지가 넓어지고 있습니다. 정형외과용 보조기 및 수처리기의 기술 혁신은 노견의 관절염 치료를 위한 전인적 관절염 치료를 더욱 지원하고 있습니다.
어떤 시장 세분화가개 관절염 치료제에 대한 수요를 주도하고 있는가?
반려견 관절염 치료제에 대한 수요는 반려동물 의약품, 동물병원, 반려동물 보험사, 온라인 반려동물 건강 소매업체 등 여러 부문에 걸쳐 성장하고 있습니다. 비스테로이드성 항염증약(NSAIDs), 진통제(An analgesics), 재생 의약품(Regenerative medicines)을 포함한 의약품 부문은 여전히 시장 매출에 가장 큰 기여를 하고 있습니다. 동물병원에서는 물리치료와 생활습관 개선을 포함한 관절염 관리 프로그램을 제공하는 곳이 늘고 있습니다. 반려동물 보험사는 고급 관절염 치료를 보장함으로써 시장 성장에 중요한 역할을 하고 있으며, 반려동물 보호자들이 보다 쉽게 접근할 수 있도록 하고 있습니다. 또한 소비자 직접 판매 반려동물 건강 브랜드는 E-Commerce 채널을 통해 관절 보조제 및 치료용 식품의 가용성을 확대하고 있습니다.
개 관절염 치료제 시장의 성장을 가속하는 요인은 무엇인가?
개 관절염 치료제 시장의 성장은 반려동물의 수명 연장, 관절 건강에 대한 인식 증가, 수의학적 치료법의 발전 등 여러 가지 요인에 의해 주도되고 있습니다. 반려동물 예방 의료 및 조기 개입 전략으로의 전환은 진단 툴 및 장기 관절염 관리 계획에 대한 수요를 증가시키고 있습니다. 반려동물 보험 산업이 확대되면서 고급 관절염 치료의 가격도 저렴해졌고, 고가의 치료 옵션에 대한 접근성이 높아졌습니다. 또한 온라인 동물약국 및 원격의료 서비스의 등장으로 반려동물 보호자가 여러 치료 옵션을 고려할 수 있게 되어 관절염 치료에 대한 접근성이 향상되었습니다. 반려동물 보호자들이 노령견의 삶의 질을 최우선으로 생각함에 따라 혁신적이고 효과적인 관절염 치료제에 대한 수요가 증가할 것으로 예측됩니다.
부문
치료 유형(약물 치료, 보충제 치료, 외과적 시술, 기타 치료 유형), 관절염 유형(골관절염 치료, 골연골증 치료, 류마티스 관절염 치료, 외상성 관절염 치료)
조사 대상 기업의 예
Adequan Canine(American Regent Animal Health)
American Regent, Inc.
Boehringer Ingelheim Animal Health
Cartrophen Vet(Arthropharm)
Cosequin(Nutramax Laboratories)
Dasuquin(Nutramax Laboratories)
Elanco Animal Health
Liquid Health, Inc.
Matsun Nutrition
Nutramax Laboratories Veterinary Sciences, Inc.
Nutri-Vet, LLC
Parnell Pharmaceuticals Holdings Ltd.
Pet Tech Labs
Synflex America Inc.
Thorne Research Inc.
Vetalogica
VetIQ
Wuffes
YuMOVE(Lintbells)
Zoetis Inc.
AI 통합
Global Industry Analysts는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.
Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.
관세 영향 계수
Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.
목차
제1장 조사 방법
제2장 개요
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
스페인
러시아
기타 유럽
아시아태평양
호주
인도
한국
기타 아시아태평양
라틴아메리카
아르헨티나
브라질
멕시코
기타 라틴아메리카
중동
이란
이스라엘
사우디아라비아
아랍에미리트
기타 중동
아프리카
제4장 경쟁
KSA
영문 목차
영문목차
Global Canine Arthritis Treatment Market to Reach US$3.0 Billion by 2030
The global market for Canine Arthritis Treatment estimated at US$2.4 Billion in the year 2024, is expected to reach US$3.0 Billion by 2030, growing at a CAGR of 3.5% over the analysis period 2024-2030. Drugs Treatment, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Supplements Treatment segment is estimated at 3.4% CAGR over the analysis period.
The U.S. Market is Estimated at US$661.0 Million While China is Forecast to Grow at 6.7% CAGR
The Canine Arthritis Treatment market in the U.S. is estimated at US$661.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$600.4 Million by the year 2030 trailing a CAGR of 6.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.4% and 2.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.0% CAGR.
Why Is Canine Arthritis a Growing Concern Among Pet Owners?
Canine arthritis has become a major health concern, particularly as advances in veterinary care lead to longer lifespans for dogs. This degenerative joint disease affects millions of pets globally, causing pain, reduced mobility, and a decline in quality of life. The increasing awareness among pet owners about joint health, combined with the rise in pet humanization trends, has significantly expanded the market for arthritis treatments. Veterinarians are now focusing on early diagnosis and multimodal treatment approaches to improve outcomes, driving demand for both pharmaceutical and non-pharmaceutical solutions. Additionally, the growing prevalence of obesity in dogs has exacerbated arthritis cases, further fueling the need for effective treatment options.
How Are Innovations in Veterinary Medicine Improving Arthritis Management?
The canine arthritis treatment market has seen significant advancements in recent years, with novel therapies offering improved pain relief and joint support. Regenerative medicine, including stem cell therapy and platelet-rich plasma (PRP) treatments, is gaining traction for its potential to repair damaged cartilage and slow disease progression. Advances in biologic drugs, such as monoclonal antibodies targeting pain pathways, have also revolutionized arthritis management, providing longer-lasting relief with fewer side effects. Additionally, the development of nutraceuticals, including omega-3 fatty acids and glucosamine supplements, has expanded non-invasive treatment options. Technological innovations in orthopedic braces and hydrotherapy equipment further support holistic arthritis care for aging dogs.
Which Market Segments Are Driving Demand for Canine Arthritis Treatments?
The demand for canine arthritis treatments is growing across multiple segments, including pet pharmaceuticals, veterinary clinics, pet insurance providers, and online pet health retailers. The pharmaceutical segment, encompassing NSAIDs, analgesics, and regenerative medicines, remains the largest contributor to market revenue. Veterinary clinics are increasingly offering specialized arthritis management programs, incorporating physiotherapy and lifestyle modifications. Pet insurance companies are playing a key role in market growth by covering advanced arthritis treatments, making them more accessible to pet owners. Additionally, direct-to-consumer pet health brands are expanding the availability of joint supplements and therapeutic diets through e-commerce channels.
What Factors Are Driving the Growth of the Canine Arthritis Treatment Market?
The growth in the canine arthritis treatment market is driven by several factors, including increasing pet longevity, rising awareness of joint health, and advancements in veterinary therapeutics. The shift toward preventive pet care and early intervention strategies has boosted demand for diagnostic tools and long-term arthritis management plans. The expanding pet insurance industry has also facilitated greater access to expensive treatment options, making advanced arthritis therapies more affordable. Additionally, the rise of online veterinary pharmacies and telemedicine services has improved accessibility to arthritis treatments, allowing pet owners to explore multiple care options. As pet owners continue to prioritize quality of life for their aging dogs, the demand for innovative and effective arthritis treatments is expected to rise.
SCOPE OF STUDY:
The report analyzes the Canine Arthritis Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Treatment Type (Drugs Treatment, Supplements Treatment, Surgical Procedures, Other Treatment Types); Arthritis Type (Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment, Traumatic Arthritis Treatment)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 42 Featured) -
Adequan Canine (American Regent Animal Health)
American Regent, Inc.
Boehringer Ingelheim Animal Health
Cartrophen Vet (Arthropharm)
Cosequin (Nutramax Laboratories)
Dasuquin (Nutramax Laboratories)
Elanco Animal Health
Liquid Health, Inc.
Matsun Nutrition
Nutramax Laboratories Veterinary Sciences, Inc.
Nutri-Vet, LLC
Parnell Pharmaceuticals Holdings Ltd.
Pet Tech Labs
Synflex America Inc.
Thorne Research Inc.
Vetalogica
VetIQ
Wuffes
YuMOVE (Lintbells)
Zoetis Inc.
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Tariff Impact on Global Supply Chain Patterns
Canine Arthritis Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Aging Pet Population Driving Demand for Arthritis Treatment Products
Rising Humanization of Pets Fueling Investment in Premium Care Solutions
Advancements in Veterinary Diagnostics Increasing Early Arthritis Detection
Growth in Natural and Alternative Therapy Solutions Attracting Wellness-Focused Pet Owners
Increased Awareness of Pain Management Solutions Through Digital Platforms
Expansion of Tele-Veterinary Services Improving Access to Treatment Options
Integration of Joint Supplements Into Regular Pet Care Routines
Surge in Demand for Non-Invasive Pain Relief Technologies for Pets
Growing Adoption of Nutraceuticals and CBD-Based Arthritis Products
Development of Breed-Specific and Weight-Specific Treatment Plans Improving Outcomes
Innovation in Long-Acting Injectable Therapies Driving Compliance and Ease of Use
Emergence of Wearable Pet Health Trackers Aiding Continuous Mobility Monitoring
Expanding Pet Insurance Coverage Increasing Affordability of Treatments
Strategic Partnerships Between Pet Clinics and Pharmaceutical Companies
Increased Consumer Education Around Early Signs and Prevention Boosting Proactive Treatment
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Canine Arthritis Treatment Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 3: World 6-Year Perspective for Canine Arthritis Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2025 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Drugs Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 5: World 6-Year Perspective for Drugs Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
TABLE 6: World Recent Past, Current & Future Analysis for Supplements Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 7: World 6-Year Perspective for Supplements Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Surgical Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 9: World 6-Year Perspective for Surgical Procedures by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 11: World 6-Year Perspective for Other Treatment Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
TABLE 12: World Recent Past, Current & Future Analysis for Osteoarthritis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 13: World 6-Year Perspective for Osteoarthritis Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Osteochondrosis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 15: World 6-Year Perspective for Osteochondrosis Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Rheumatoid Arthritis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 17: World 6-Year Perspective for Rheumatoid Arthritis Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
TABLE 18: World Recent Past, Current & Future Analysis for Traumatic Arthritis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 19: World 6-Year Perspective for Traumatic Arthritis Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Canine Arthritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 20: USA Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 21: USA 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
TABLE 22: USA Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 23: USA 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
CANADA
TABLE 24: Canada Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 25: Canada 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
TABLE 26: Canada Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 27: Canada 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
JAPAN
Canine Arthritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 28: Japan Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 29: Japan 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
TABLE 30: Japan Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 31: Japan 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
CHINA
Canine Arthritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 32: China Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 33: China 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
TABLE 34: China Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 35: China 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
EUROPE
Canine Arthritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 36: Europe Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 37: Europe 6-Year Perspective for Canine Arthritis Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2025 & 2030
TABLE 38: Europe Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 39: Europe 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
TABLE 40: Europe Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 41: Europe 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
FRANCE
Canine Arthritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 42: France Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 43: France 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
TABLE 44: France Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 45: France 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
GERMANY
Canine Arthritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 46: Germany Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 47: Germany 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
TABLE 48: Germany Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 49: Germany 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
ITALY
TABLE 50: Italy Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 51: Italy 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
TABLE 52: Italy Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 53: Italy 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
UNITED KINGDOM
Canine Arthritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 54: UK Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 55: UK 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
TABLE 56: UK Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 57: UK 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
SPAIN
TABLE 58: Spain Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 59: Spain 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
TABLE 60: Spain Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 61: Spain 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
RUSSIA
TABLE 62: Russia Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 63: Russia 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
TABLE 64: Russia Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 65: Russia 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
REST OF EUROPE
TABLE 66: Rest of Europe Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 67: Rest of Europe 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
TABLE 68: Rest of Europe Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 69: Rest of Europe 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
ASIA-PACIFIC
Canine Arthritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 70: Asia-Pacific Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 71: Asia-Pacific 6-Year Perspective for Canine Arthritis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2025 & 2030
TABLE 72: Asia-Pacific Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 73: Asia-Pacific 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
TABLE 74: Asia-Pacific Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 75: Asia-Pacific 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
AUSTRALIA
Canine Arthritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
TABLE 76: Australia Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 77: Australia 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
TABLE 78: Australia Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 79: Australia 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
INDIA
Canine Arthritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
TABLE 80: India Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 81: India 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
TABLE 82: India Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 83: India 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
SOUTH KOREA
TABLE 84: South Korea Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 85: South Korea 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
TABLE 86: South Korea Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 87: South Korea 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
REST OF ASIA-PACIFIC
TABLE 88: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 89: Rest of Asia-Pacific 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
TABLE 90: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 91: Rest of Asia-Pacific 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
LATIN AMERICA
Canine Arthritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
TABLE 92: Latin America Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 93: Latin America 6-Year Perspective for Canine Arthritis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2025 & 2030
TABLE 94: Latin America Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 95: Latin America 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
TABLE 96: Latin America Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 97: Latin America 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
ARGENTINA
TABLE 98: Argentina Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 99: Argentina 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
TABLE 100: Argentina Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 101: Argentina 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
BRAZIL
TABLE 102: Brazil Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 103: Brazil 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
TABLE 104: Brazil Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 105: Brazil 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
MEXICO
TABLE 106: Mexico Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 107: Mexico 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
TABLE 108: Mexico Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 109: Mexico 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
REST OF LATIN AMERICA
TABLE 110: Rest of Latin America Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 111: Rest of Latin America 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
TABLE 112: Rest of Latin America Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 113: Rest of Latin America 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
MIDDLE EAST
Canine Arthritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
TABLE 114: Middle East Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 115: Middle East 6-Year Perspective for Canine Arthritis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2025 & 2030
TABLE 116: Middle East Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 117: Middle East 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
TABLE 118: Middle East Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 119: Middle East 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
IRAN
TABLE 120: Iran Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 121: Iran 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
TABLE 122: Iran Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 123: Iran 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
ISRAEL
TABLE 124: Israel Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 125: Israel 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
TABLE 126: Israel Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 127: Israel 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
SAUDI ARABIA
TABLE 128: Saudi Arabia Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 129: Saudi Arabia 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
TABLE 130: Saudi Arabia Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 131: Saudi Arabia 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
UNITED ARAB EMIRATES
TABLE 132: UAE Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 133: UAE 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
TABLE 134: UAE Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 135: UAE 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
REST OF MIDDLE EAST
TABLE 136: Rest of Middle East Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 137: Rest of Middle East 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
TABLE 138: Rest of Middle East Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 139: Rest of Middle East 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
AFRICA
Canine Arthritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
TABLE 140: Africa Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 141: Africa 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
TABLE 142: Africa Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 143: Africa 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030